2Mok CC,Ho CT,Siu YP,et al.Treatment of diffuse proliferative lupus glomerulonephritis:a comparison of two cyclophosphamide-containing regimens.Am J Kidney Dis,2001,38:256-264.
3Mok CC,Ho CT,Chan KW,et al.Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine.Arthritis Rheum,2002,46:1003-1013.
4Hill GS,Delahousse M,Nochy D,et al.Class Ⅳ-S versus class Ⅳ-G lupus nephritis:Clinical and morphologic differences suggesting different pathogenesis.Kidney Int,2005,68:2288-2297.
5Yokoyama H,Wada T,Ham A,et al.The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese.Kidney Int,2004,66:2382-2388.
6Kim YG,Kim HW,Cho YM,et al.The difference between lupus nephritis class Ⅳ-G and Ⅳ-S in Koreans:focus on the response to cyclophosphamide induction treatment.Rheumatology(Oxford),2008,47:311-314.
7Hiramatsu N,Kuroiwa T,Ikeuchi H,et al.Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions.Rheumatology (Oxford),2008,47:702-707.
8Najafi CC,Korbet SM,Lewis FJ,et al.Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis.Kidney Int,2001.59:2156-2163.
9Sloan RP,Schwartz MM,Korbet SM,et al.Long-term outcome in systemic lupus erythematosus membranous glomeruionephritis.J Am Soc Nephrol,1996,7:299-305.
10Bao H,Liu ZH,Xie HL,et al,Successful treatment of class Ⅴ+Ⅳ lupus uephritis with muhitarget therapy.J Am Soe Nephrol,2008,19:2001-2010.
1Amissah-Aythur MB, Gordon C. GPs have key role in shared careof patients with SLE. Practitioner, 2009,253 ( 1724 ) : 19- 24. Eknoyan G, Lameire N.DKIGO clinical practice guideline for glo merulonephritis lupus nephritis [J ]. Kidney Int, 2012, 2(2) :221-232.
2Gorriz JL, Martinez -Castelao A. Proteinuria: detection and role innative renal disease progression [J ]. Transplantation Rev,2012,26(1 ) :3-13.
3Kidney Disease Improving Global Outcomes Kid ney. KDGO Clinical Practice Guideline for Glomerulonephritis [ J ]. Kidney International Supplements, 2012,2 : 221-232.
4Bertsias GK,Tektonidou M, Zahir Amourz Z, et al. Joint Euro- pean League Against Rheumatism and European Renal Asso- ciation-European Dialysis and Transplant Associantion (EU- LAR/ERQ-EDTA)recommend-dation for the manggement of adult and paediatric lupus nephritis [ J ]. Ann Rheum Dis, 2012,71 ( 11 ) : 1771-1782.
